C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 263/20 (2006.01) A61K 31/40 (2006.01) A61K 31/421 (2006.01) A61P 3/06 (2006.01)
Patent
CA 2681628
The invention relates to novel oxazolidinones their derivatives, pharmaceutically acceptable salts, solvates, and hydrates thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering cholesterol ester transfer protein inhibitors.
L'invention concerne de nouvelles oxazolidinones, leurs dérivés, des sels pharmaceutiquement acceptables, des solvates, et des hydrates de celles-ci. L'invention concerne également des compositions comprenant un composé de cette invention et l'utilisation de telles compositions dans des procédés de traitement de maladies et d'infections qui sont avantageusement traitées par l'administration d'inhibiteurs de protéine de transfert d'ester de cholestérol.
Tung Roger
Concert Pharmaceuticals Inc.
Gowling Lafleur Henderson Llp
LandOfFree
Inhibitors of cholesterol ester transfer protein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of cholesterol ester transfer protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of cholesterol ester transfer protein will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1573230